Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Hui Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8726-7098; OpenAlex author ID A5029519877, A5100323374, A5126368230; NIH RePORTER profile ID 8899648. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 6)
Trials
0
Grants
1
Labs led
1
Collaborators
18
Papers, trials and grants by year

2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 3 papers, 1 grant

Papers 8

  1. High-Sensitive Spatial Proteomics for Pancreatic Cancer Progression Analysis. Last author DOI 10.1021/acs.analchem.5c01928↗
  2. Signatures of Pancreatic Ductal Adenocarcinoma Uncovered by Integrative Multi-Omics Analysis. Last author DOI 10.3390/cancers18040687↗
  3. A Biomarker Panel for the Detection of Pancreatic Cancer. Last author DOI 10.3390/cancers18091397↗
  4. Detection of Pancreatic Ductal Adenocarcinoma-Associated Proteins in Serum. Last author DOI 10.1016/j.mcpro.2023.100687↗
  5. The next "sweet" spot for pancreatic ductal adenocarcinoma: Glycoprotein for early detection. Last author DOI 10.1002/mas.21748↗
  6. Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer. Co-author DOI 10.1038/s41588-022-01157-1↗
  7. Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s12014-022-09373-x↗
  8. Proteogenomic characterization of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.cell.2021.08.023↗

Grants 1

  1. Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions U01CA274514↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniel W. Chan · 4 shared papers, 1 shared grant, 2022–2026 · strength 1.75
  2. Randall E. Brand · 2 shared papers, 1 shared grant, 2026 · strength 1.40
  3. Zhen Zhang · 1 shared paper, 1 shared grant, 2026 · strength 1.13
  4. T. Mamie Lih · 3 shared papers, 2024–2026 · strength 0.93
  5. Ralph H. Hruban · 3 shared papers, 2022–2026 · strength 0.62
  6. Christine Worthington · 2 shared papers, 2026 · strength 0.54
  7. Yuefan Wang · 2 shared papers, 2023–2026 · strength 0.49
  8. Benjamin Miao · 1 shared paper, 2026 · strength 0.43
  9. Qing Kay Li · 2 shared papers, 2022–2026 · strength 0.39
  10. Oliver F. Bathe · 2 shared papers, 2022–2024 · strength 0.35
  11. Jongmin Jacob Woo · 1 shared paper, 2026 · strength 0.27
  12. Amer H. Zureikat · 1 shared paper, 2026 · strength 0.27
  13. Aatur Dilip Singhi · 1 shared paper, 2026 · strength 0.27
  14. Alessandro Paniccia · 1 shared paper, 2026 · strength 0.27
  15. Liwei Cao · 1 shared paper, 2024 · strength 0.23
  16. Yuanwei Xu · 1 shared paper, 2023 · strength 0.22
  17. Daniel Cui Zhou · 1 shared paper, 2022 · strength 0.12
  18. Bing Zhang · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.